nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—NR3C1—hypertension	0.375	1	CbGaD
Desonide—NR3C1—Spironolactone—hypertension	0.105	1	CbGbCtD
Desonide—Hydrocortamate—Eplerenone—hypertension	0.0591	0.18	CrCrCtD
Desonide—Hydrocortamate—Spironolactone—hypertension	0.0514	0.157	CrCrCtD
Desonide—Fludrocortisone—Eplerenone—hypertension	0.0498	0.152	CrCrCtD
Desonide—Testolactone—Spironolactone—hypertension	0.0484	0.147	CrCrCtD
Desonide—Fludrocortisone—Spironolactone—hypertension	0.0433	0.132	CrCrCtD
Desonide—Hydrocortisone—Eplerenone—hypertension	0.0406	0.124	CrCrCtD
Desonide—Hydrocortisone—Spironolactone—hypertension	0.0353	0.108	CrCrCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—hypertension	0.00154	0.0431	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—SRF—hypertension	0.00123	0.0343	CbGpPWpGaD
Desonide—NR3C1—urine—hypertension	0.00117	0.201	CbGeAlD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC5—hypertension	0.000795	0.0222	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—RCHY1—hypertension	0.000762	0.0213	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—SRF—hypertension	0.000704	0.0197	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—GATA6—hypertension	0.000701	0.0196	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—NR3C2—hypertension	0.000611	0.0171	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—hypertension	0.000592	0.0166	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—hypertension	0.00057	0.0159	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—hypertension	0.000568	0.0159	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—hypertension	0.000552	0.0154	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALAS1—hypertension	0.000552	0.0154	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—hypertension	0.000521	0.0146	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—hypertension	0.000512	0.0143	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—hypertension	0.000492	0.0138	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—hypertension	0.000485	0.0136	CbGpPWpGaD
Desonide—NR3C1—cardiac ventricle—hypertension	0.000457	0.0783	CbGeAlD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—hypertension	0.000449	0.0126	CbGpPWpGaD
Desonide—NR3C1—myocardium—hypertension	0.00043	0.0736	CbGeAlD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—hypertension	0.000422	0.0118	CbGpPWpGaD
Desonide—Prednisone—HSD11B1—hypertension	0.000417	0.076	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—NFATC2—hypertension	0.000387	0.0108	CbGpPWpGaD
Desonide—Amcinonide—ANXA1—hypertension	0.000382	0.0697	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hypertension	0.000373	0.0104	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—hypertension	0.000351	0.00983	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—GATA4—hypertension	0.00035	0.00979	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—ESR2—hypertension	0.000349	0.00975	CbGpPWpGaD
Desonide—NR3C1—brainstem—hypertension	0.000347	0.0594	CbGeAlD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—hypertension	0.000343	0.00959	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—RETN—hypertension	0.00034	0.00951	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—DUSP1—hypertension	0.000338	0.00946	CbGpPWpGaD
Desonide—NR3C1—nephron tubule—hypertension	0.000315	0.054	CbGeAlD
Desonide—NR3C1—adrenal cortex—hypertension	0.00031	0.0531	CbGeAlD
Desonide—NR3C1—Nuclear Receptors—AR—hypertension	0.000308	0.00862	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—F7—hypertension	0.000307	0.0086	CbGpPWpGaD
Desonide—NR3C1—heart—hypertension	0.0003	0.0514	CbGeAlD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—hypertension	0.000299	0.00836	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—NPPA—hypertension	0.000298	0.00834	CbGpPWpGaD
Desonide—NR3C1—smooth muscle tissue—hypertension	0.000298	0.051	CbGeAlD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—hypertension	0.000296	0.00829	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—KCNJ8—hypertension	0.000294	0.00822	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—KCNQ1—hypertension	0.000294	0.00822	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypertension	0.000293	0.00818	CbGpPWpGaD
Desonide—NR3C1—decidua—hypertension	0.000292	0.05	CbGeAlD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—hypertension	0.000285	0.00798	CbGpPWpGaD
Desonide—NR3C1—cardiovascular system—hypertension	0.000283	0.0485	CbGeAlD
Desonide—NR3C1—kidney—hypertension	0.000277	0.0474	CbGeAlD
Desonide—NR3C1—Nuclear Receptors—VDR—hypertension	0.000277	0.00774	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—hypertension	0.000276	0.00771	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—ECE1—hypertension	0.000273	0.00765	CbGpPWpGaD
Desonide—NR3C1—cortex of kidney—hypertension	0.00027	0.0462	CbGeAlD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—SELE—hypertension	0.000263	0.00735	CbGpPWpGaD
Desonide—NR3C1—cardiac atrium—hypertension	0.000257	0.0439	CbGeAlD
Desonide—Fludrocortisone—NR3C2—hypertension	0.000251	0.0459	CrCbGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—EGR1—hypertension	0.00025	0.00699	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PTGIS—hypertension	0.000248	0.00694	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—MIF—hypertension	0.000248	0.00694	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SLC9A3—hypertension	0.000244	0.00681	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—AR—hypertension	0.000243	0.00681	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—HDAC1—hypertension	0.000243	0.00679	CbGpPWpGaD
Desonide—NR3C1—medulla oblongata—hypertension	0.000242	0.0414	CbGeAlD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—hypertension	0.000238	0.00667	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—AR—hypertension	0.000236	0.0066	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—PPARA—hypertension	0.000233	0.00653	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—hypertension	0.000233	0.00651	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TIMP1—hypertension	0.000226	0.00632	CbGpPWpGaD
Desonide—NR3C1—adrenal gland—hypertension	0.000224	0.0383	CbGeAlD
Desonide—NR3C1—Nuclear Receptor transcription pathway—VDR—hypertension	0.000219	0.00612	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—PPARGC1A—hypertension	0.000216	0.00604	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—AVP—hypertension	0.000213	0.00596	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TH—hypertension	0.000212	0.00594	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—GATA4—hypertension	0.000208	0.00583	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TPH1—hypertension	0.000207	0.00579	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hypertension	0.0002	0.00561	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—EGR1—hypertension	0.0002	0.0056	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—hypertension	0.000195	0.00545	CbGpPWpGaD
Desonide—NR3C1—endocrine gland—hypertension	0.000194	0.0333	CbGeAlD
Desonide—NR3C1—Nuclear Receptors—PPARG—hypertension	0.000193	0.0054	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—GJA1—hypertension	0.00019	0.00533	CbGpPWpGaD
Desonide—Hydrocortisone—CYP11B1—hypertension	0.000189	0.0345	CrCbGaD
Desonide—NR3C1—Adipogenesis—AHR—hypertension	0.000186	0.00521	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—hypertension	0.000186	0.0052	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—hypertension	0.000184	0.00516	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HADHA—hypertension	0.00018	0.00504	CbGpPWpGaD
Desonide—Hydrocortisone—CYP11B2—hypertension	0.000178	0.0325	CrCbGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—hypertension	0.000178	0.00497	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—hypertension	0.000176	0.00493	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AQP4—hypertension	0.000176	0.00493	CbGpPWpGaD
Desonide—NR3C1—central nervous system—hypertension	0.000175	0.03	CbGeAlD
Desonide—NR3C1—Circadian Clock—PPARA—hypertension	0.000174	0.00486	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypertension	0.000174	0.00486	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—hypertension	0.000173	0.00483	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—hypertension	0.000171	0.00479	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—HIF1A—hypertension	0.000169	0.00472	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—hypertension	0.000168	0.00471	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hypertension	0.000168	0.0047	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—EDN1—hypertension	0.000167	0.00467	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—hypertension	0.000166	0.00463	CbGpPWpGaD
Desonide—Prednisolone—NR3C2—hypertension	0.000165	0.0301	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—IL10—hypertension	0.000165	0.00462	CbGpPWpGaD
Desonide—Betamethasone—NR3C2—hypertension	0.000162	0.0295	CrCbGaD
Desonide—Hydrocortisone—ANXA1—hypertension	0.000161	0.0294	CrCbGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—hypertension	0.000159	0.00444	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TACR1—hypertension	0.000157	0.00439	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hypertension	0.000154	0.00432	CbGpPWpGaD
Desonide—Testolactone—CYP19A1—hypertension	0.000154	0.028	CrCbGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—hypertension	0.000152	0.00427	CbGpPWpGaD
Desonide—Dexamethasone—CYP4A11—hypertension	0.000152	0.0277	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—hypertension	0.000151	0.00423	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hypertension	0.000147	0.00411	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP1—hypertension	0.00014	0.00393	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—HIF1A—hypertension	0.000139	0.00389	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL13—hypertension	0.000139	0.00389	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—AGT—hypertension	0.000139	0.00388	CbGpPWpGaD
Desonide—Cough—Trandolapril—hypertension	0.000134	0.000922	CcSEcCtD
Desonide—Infection—Valsartan—hypertension	0.000134	0.000922	CcSEcCtD
Desonide—Rash—Isradipine—hypertension	0.000134	0.000921	CcSEcCtD
Desonide—Dermatitis—Isradipine—hypertension	0.000134	0.00092	CcSEcCtD
Desonide—Erythema—Losartan—hypertension	0.000134	0.000919	CcSEcCtD
Desonide—Cough—Enalapril—hypertension	0.000133	0.000918	CcSEcCtD
Desonide—Rash—Guanfacine—hypertension	0.000133	0.000918	CcSEcCtD
Desonide—NR3C1—Adipogenesis—ADIPOQ—hypertension	0.000133	0.00373	CbGpPWpGaD
Desonide—Infection—Olmesartan—hypertension	0.000133	0.000917	CcSEcCtD
Desonide—Dermatitis—Guanfacine—hypertension	0.000133	0.000917	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—hypertension	0.000133	0.000916	CcSEcCtD
Desonide—Headache—Isradipine—hypertension	0.000133	0.000915	CcSEcCtD
Desonide—Pruritus—Eprosartan—hypertension	0.000133	0.000914	CcSEcCtD
Desonide—Rash—Nicardipine—hypertension	0.000133	0.000914	CcSEcCtD
Desonide—Dermatitis—Nicardipine—hypertension	0.000133	0.000913	CcSEcCtD
Desonide—Headache—Guanfacine—hypertension	0.000132	0.000912	CcSEcCtD
Desonide—Nervous system disorder—Valsartan—hypertension	0.000132	0.00091	CcSEcCtD
Desonide—Headache—Nicardipine—hypertension	0.000132	0.000908	CcSEcCtD
Desonide—Cough—Telmisartan—hypertension	0.000132	0.000906	CcSEcCtD
Desonide—Nervous system disorder—Olmesartan—hypertension	0.000132	0.000905	CcSEcCtD
Desonide—Rash—Felodipine—hypertension	0.000131	0.000904	CcSEcCtD
Desonide—Rash—Metolazone—hypertension	0.000131	0.000904	CcSEcCtD
Desonide—Dermatitis—Felodipine—hypertension	0.000131	0.000904	CcSEcCtD
Desonide—Dermatitis—Metolazone—hypertension	0.000131	0.000904	CcSEcCtD
Desonide—Rash—Spironolactone—hypertension	0.000131	0.000901	CcSEcCtD
Desonide—Skin disorder—Valsartan—hypertension	0.000131	0.000901	CcSEcCtD
Desonide—Dermatitis—Spironolactone—hypertension	0.000131	0.0009	CcSEcCtD
Desonide—Headache—Metolazone—hypertension	0.000131	0.000899	CcSEcCtD
Desonide—Headache—Felodipine—hypertension	0.000131	0.000899	CcSEcCtD
Desonide—Skin disorder—Olmesartan—hypertension	0.00013	0.000897	CcSEcCtD
Desonide—Pain—Diltiazem—hypertension	0.00013	0.000897	CcSEcCtD
Desonide—Pain—Indapamide—hypertension	0.00013	0.000897	CcSEcCtD
Desonide—Headache—Spironolactone—hypertension	0.00013	0.000895	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—hypertension	0.00013	0.000893	CcSEcCtD
Desonide—Hyperhidrosis—Olmesartan—hypertension	0.00013	0.000892	CcSEcCtD
Desonide—Oedema peripheral—Ramipril—hypertension	0.00013	0.000892	CcSEcCtD
Desonide—NR3C1—Circadian Clock—SERPINE1—hypertension	0.000129	0.00362	CbGpPWpGaD
Desonide—Pruritus—Amlodipine—hypertension	0.000129	0.000888	CcSEcCtD
Desonide—Pruritus—Nisoldipine—hypertension	0.000129	0.000888	CcSEcCtD
Desonide—Pain—Carvedilol—hypertension	0.000129	0.000888	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hypertension	0.000129	0.00361	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—NOTCH1—hypertension	0.000128	0.00359	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—hypertension	0.000128	0.00358	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TAC1—hypertension	0.000128	0.00358	CbGpPWpGaD
Desonide—Cough—Captopril—hypertension	0.000128	0.000881	CcSEcCtD
Desonide—Infection—Clonidine—hypertension	0.000128	0.000878	CcSEcCtD
Desonide—Pain—Doxazosin—hypertension	0.000128	0.000878	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—hypertension	0.000127	0.000878	CcSEcCtD
Desonide—Sweating—Lisinopril—hypertension	0.000127	0.000877	CcSEcCtD
Desonide—Headache—Esmolol—hypertension	0.000127	0.000877	CcSEcCtD
Desonide—Oedema peripheral—Timolol—hypertension	0.000127	0.000872	CcSEcCtD
Desonide—Rash—Terazosin—hypertension	0.000126	0.000871	CcSEcCtD
Desonide—Dermatitis—Terazosin—hypertension	0.000126	0.00087	CcSEcCtD
Desonide—Pain—Fosinopril—hypertension	0.000126	0.000867	CcSEcCtD
Desonide—Nervous system disorder—Clonidine—hypertension	0.000126	0.000867	CcSEcCtD
Desonide—NR3C1—Adipogenesis—SLC2A4—hypertension	0.000126	0.00352	CbGpPWpGaD
Desonide—Headache—Terazosin—hypertension	0.000126	0.000865	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—hypertension	0.000125	0.00351	CbGpPWpGaD
Desonide—Pain—Eplerenone—hypertension	0.000125	0.000862	CcSEcCtD
Desonide—Skin disorder—Clonidine—hypertension	0.000125	0.000859	CcSEcCtD
Desonide—Infection—Trandolapril—hypertension	0.000124	0.000857	CcSEcCtD
Desonide—Prednicarbate—NR3C1—hypertension	0.000124	0.0227	CrCbGaD
Desonide—Clocortolone—NR3C1—hypertension	0.000124	0.0227	CrCbGaD
Desonide—Pain—Nifedipine—hypertension	0.000124	0.000856	CcSEcCtD
Desonide—Cough—Perindopril—hypertension	0.000124	0.000855	CcSEcCtD
Desonide—Hyperhidrosis—Clonidine—hypertension	0.000124	0.000855	CcSEcCtD
Desonide—Cough—Irbesartan—hypertension	0.000124	0.000852	CcSEcCtD
Desonide—Pain—Verapamil—hypertension	0.000124	0.000852	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—hypertension	0.000124	0.00346	CbGpPWpGaD
Desonide—Rash—Acebutolol—hypertension	0.000123	0.000849	CcSEcCtD
Desonide—Dermatitis—Acebutolol—hypertension	0.000123	0.000848	CcSEcCtD
Desonide—Nervous system disorder—Trandolapril—hypertension	0.000123	0.000846	CcSEcCtD
Desonide—Cough—Hydrochlorothiazide—hypertension	0.000123	0.000845	CcSEcCtD
Desonide—Headache—Acebutolol—hypertension	0.000123	0.000844	CcSEcCtD
Desonide—Infection—Telmisartan—hypertension	0.000122	0.000842	CcSEcCtD
Desonide—Rash—Labetalol—hypertension	0.000122	0.000841	CcSEcCtD
Desonide—Dermatitis—Labetalol—hypertension	0.000122	0.00084	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—SST—hypertension	0.000122	0.00341	CbGpPWpGaD
Desonide—Skin disorder—Trandolapril—hypertension	0.000122	0.000838	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—hypertension	0.000122	0.0034	CbGpPWpGaD
Desonide—Headache—Labetalol—hypertension	0.000121	0.000836	CcSEcCtD
Desonide—Pruritus—Metoprolol—hypertension	0.000121	0.000834	CcSEcCtD
Desonide—Pruritus—Guanabenz—hypertension	0.000121	0.000834	CcSEcCtD
Desonide—Hyperhidrosis—Trandolapril—hypertension	0.000121	0.000834	CcSEcCtD
Desonide—Nervous system disorder—Telmisartan—hypertension	0.000121	0.000831	CcSEcCtD
Desonide—Hyperhidrosis—Enalapril—hypertension	0.000121	0.00083	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Perindopril—hypertension	0.00012	0.000829	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—hypertension	0.00012	0.000826	CcSEcCtD
Desonide—Dexamethasone—ANXA1—hypertension	0.00012	0.0219	CrCbGaD
Desonide—Cough—Betaxolol—hypertension	0.00012	0.000823	CcSEcCtD
Desonide—Skin disorder—Telmisartan—hypertension	0.00012	0.000823	CcSEcCtD
Desonide—Hyperhidrosis—Telmisartan—hypertension	0.000119	0.000819	CcSEcCtD
Desonide—Mediastinal disorder—Ramipril—hypertension	0.000119	0.000816	CcSEcCtD
Desonide—Pharyngitis—Lisinopril—hypertension	0.000118	0.000815	CcSEcCtD
Desonide—Rash—Eprosartan—hypertension	0.000118	0.000815	CcSEcCtD
Desonide—Dermatitis—Eprosartan—hypertension	0.000118	0.000814	CcSEcCtD
Desonide—Diflorasone—NR3C1—hypertension	0.000118	0.0215	CrCbGaD
Desonide—Headache—Eprosartan—hypertension	0.000118	0.00081	CcSEcCtD
Desonide—Oedema peripheral—Lisinopril—hypertension	0.000118	0.000809	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—hypertension	0.000117	0.000806	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—FOS—hypertension	0.000117	0.00327	CbGpPWpGaD
Desonide—Cough—Losartan—hypertension	0.000117	0.000802	CcSEcCtD
Desonide—Mediastinal disorder—Timolol—hypertension	0.000116	0.000798	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—hypertension	0.000116	0.000797	CcSEcCtD
Desonide—Mental disorder—Ramipril—hypertension	0.000115	0.000793	CcSEcCtD
Desonide—Infection—Irbesartan—hypertension	0.000115	0.000792	CcSEcCtD
Desonide—Rash—Amlodipine—hypertension	0.000115	0.000791	CcSEcCtD
Desonide—Rash—Nisoldipine—hypertension	0.000115	0.000791	CcSEcCtD
Desonide—Desoximetasone—NR3C1—hypertension	0.000115	0.021	CrCbGaD
Desonide—Dermatitis—Amlodipine—hypertension	0.000115	0.000791	CcSEcCtD
Desonide—Dermatitis—Nisoldipine—hypertension	0.000115	0.000791	CcSEcCtD
Desonide—Pain—Olmesartan—hypertension	0.000115	0.000789	CcSEcCtD
Desonide—Erythema—Ramipril—hypertension	0.000114	0.000788	CcSEcCtD
Desonide—Headache—Amlodipine—hypertension	0.000114	0.000786	CcSEcCtD
Desonide—Headache—Nisoldipine—hypertension	0.000114	0.000786	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CCL2—hypertension	0.000114	0.00319	CbGpPWpGaD
Desonide—Nervous system disorder—Perindopril—hypertension	0.000114	0.000784	CcSEcCtD
Desonide—Nervous system disorder—Irbesartan—hypertension	0.000114	0.000782	CcSEcCtD
Desonide—Loteprednol—NR3C1—hypertension	0.000113	0.0207	CrCbGaD
Desonide—Skin disorder—Perindopril—hypertension	0.000113	0.000777	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—ESR2—hypertension	0.000113	0.00315	CbGpPWpGaD
Desonide—Mental disorder—Timolol—hypertension	0.000113	0.000775	CcSEcCtD
Desonide—Skin disorder—Irbesartan—hypertension	0.000112	0.000774	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hypertension	0.000112	0.00315	CbGpPWpGaD
Desonide—Hyperhidrosis—Perindopril—hypertension	0.000112	0.000773	CcSEcCtD
Desonide—Hyperhidrosis—Irbesartan—hypertension	0.000112	0.000771	CcSEcCtD
Desonide—Erythema—Timolol—hypertension	0.000112	0.000771	CcSEcCtD
Desonide—Fludrocortisone—AR—hypertension	0.000112	0.0204	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TH—hypertension	0.000112	0.00313	CbGpPWpGaD
Desonide—Infection—Betaxolol—hypertension	0.000111	0.000765	CcSEcCtD
Desonide—Hyperhidrosis—Hydrochlorothiazide—hypertension	0.000111	0.000764	CcSEcCtD
Desonide—Nervous system disorder—Furosemide—hypertension	0.000111	0.000763	CcSEcCtD
Desonide—Pain—Clonidine—hypertension	0.00011	0.000756	CcSEcCtD
Desonide—Skin disorder—Furosemide—hypertension	0.00011	0.000755	CcSEcCtD
Desonide—Nervous system disorder—Betaxolol—hypertension	0.00011	0.000755	CcSEcCtD
Desonide—Hyperhidrosis—Furosemide—hypertension	0.000109	0.000752	CcSEcCtD
Desonide—Skin disorder—Betaxolol—hypertension	0.000109	0.000748	CcSEcCtD
Desonide—NR3C1—Adipogenesis—PPARGC1A—hypertension	0.000108	0.00304	CbGpPWpGaD
Desonide—Infection—Losartan—hypertension	0.000108	0.000745	CcSEcCtD
Desonide—Hyperhidrosis—Betaxolol—hypertension	0.000108	0.000744	CcSEcCtD
Desonide—Rash—Guanabenz—hypertension	0.000108	0.000744	CcSEcCtD
Desonide—Rash—Metoprolol—hypertension	0.000108	0.000744	CcSEcCtD
Desonide—Dermatitis—Guanabenz—hypertension	0.000108	0.000743	CcSEcCtD
Desonide—Dermatitis—Metoprolol—hypertension	0.000108	0.000743	CcSEcCtD
Desonide—Pruritus—Diltiazem—hypertension	0.000108	0.000742	CcSEcCtD
Desonide—Pruritus—Indapamide—hypertension	0.000108	0.000742	CcSEcCtD
Desonide—Mediastinal disorder—Lisinopril—hypertension	0.000108	0.00074	CcSEcCtD
Desonide—Beclomethasone—CYP3A5—hypertension	0.000107	0.0196	CrCbGaD
Desonide—Headache—Guanabenz—hypertension	0.000107	0.000739	CcSEcCtD
Desonide—Headache—Metoprolol—hypertension	0.000107	0.000739	CcSEcCtD
Desonide—Nervous system disorder—Losartan—hypertension	0.000107	0.000736	CcSEcCtD
Desonide—Pruritus—Carvedilol—hypertension	0.000107	0.000735	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—NR3C2—hypertension	0.000106	0.00295	CbGpPWpGaD
Desonide—Pruritus—Doxazosin—hypertension	0.000106	0.000726	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—EGR1—hypertension	0.000105	0.00295	CbGpPWpGaD
Desonide—Hyperhidrosis—Losartan—hypertension	0.000105	0.000725	CcSEcCtD
Desonide—Pain—Telmisartan—hypertension	0.000105	0.000724	CcSEcCtD
Desonide—Mental disorder—Lisinopril—hypertension	0.000105	0.000719	CcSEcCtD
Desonide—Pruritus—Fosinopril—hypertension	0.000104	0.000718	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hypertension	0.000104	0.00291	CbGpPWpGaD
Desonide—Erythema—Lisinopril—hypertension	0.000104	0.000715	CcSEcCtD
Desonide—Pruritus—Eplerenone—hypertension	0.000104	0.000713	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—hypertension	0.000103	0.00288	CbGpPWpGaD
Desonide—Pruritus—Nifedipine—hypertension	0.000103	0.000708	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypertension	0.000103	0.00288	CbGpPWpGaD
Desonide—Pruritus—Verapamil—hypertension	0.000102	0.000705	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—HDAC1—hypertension	0.000102	0.00286	CbGpPWpGaD
Desonide—Flurandrenolide—NR3C1—hypertension	0.000101	0.0183	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GJA1—hypertension	0.0001	0.00281	CbGpPWpGaD
Desonide—Cough—Ramipril—hypertension	9.99e-05	0.000688	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CDKN2A—hypertension	9.96e-05	0.00279	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AR—hypertension	9.95e-05	0.00278	CbGpPWpGaD
Desonide—Pain—Perindopril—hypertension	9.94e-05	0.000684	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—hypertension	9.92e-05	0.00278	CbGpPWpGaD
Desonide—Rash—Propranolol—hypertension	9.92e-05	0.000683	CcSEcCtD
Desonide—Dermatitis—Propranolol—hypertension	9.91e-05	0.000682	CcSEcCtD
Desonide—Pain—Irbesartan—hypertension	9.9e-05	0.000682	CcSEcCtD
Desonide—NR3C1—Adipogenesis—LPL—hypertension	9.88e-05	0.00276	CbGpPWpGaD
Desonide—Pain—Hydrochlorothiazide—hypertension	9.82e-05	0.000676	CcSEcCtD
Desonide—Cough—Timolol—hypertension	9.77e-05	0.000672	CcSEcCtD
Desonide—Hydrocortamate—NR3C1—hypertension	9.73e-05	0.0177	CrCbGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	9.68e-05	0.000666	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—EP300—hypertension	9.67e-05	0.00271	CbGpPWpGaD
Desonide—Pain—Furosemide—hypertension	9.66e-05	0.000665	CcSEcCtD
Desonide—Rash—Indapamide—hypertension	9.6e-05	0.000661	CcSEcCtD
Desonide—Rash—Diltiazem—hypertension	9.6e-05	0.000661	CcSEcCtD
Desonide—Dermatitis—Indapamide—hypertension	9.59e-05	0.00066	CcSEcCtD
Desonide—Dermatitis—Diltiazem—hypertension	9.59e-05	0.00066	CcSEcCtD
Desonide—Pain—Betaxolol—hypertension	9.56e-05	0.000658	CcSEcCtD
Desonide—Headache—Diltiazem—hypertension	9.54e-05	0.000657	CcSEcCtD
Desonide—Headache—Indapamide—hypertension	9.54e-05	0.000657	CcSEcCtD
Desonide—Pruritus—Valsartan—hypertension	9.53e-05	0.000656	CcSEcCtD
Desonide—Rash—Carvedilol—hypertension	9.51e-05	0.000655	CcSEcCtD
Desonide—Dermatitis—Carvedilol—hypertension	9.5e-05	0.000654	CcSEcCtD
Desonide—Pruritus—Olmesartan—hypertension	9.49e-05	0.000653	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—hypertension	9.49e-05	0.00265	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	9.46e-05	0.000651	CcSEcCtD
Desonide—Headache—Carvedilol—hypertension	9.45e-05	0.00065	CcSEcCtD
Desonide—Dexamethasone—NR3C2—hypertension	9.41e-05	0.0172	CrCbGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—SRC—hypertension	9.41e-05	0.00263	CbGpPWpGaD
Desonide—Rash—Doxazosin—hypertension	9.4e-05	0.000647	CcSEcCtD
Desonide—Dermatitis—Doxazosin—hypertension	9.4e-05	0.000647	CcSEcCtD
Desonide—NR3C1—Circadian Clock—EP300—hypertension	9.39e-05	0.00263	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—hypertension	9.38e-05	0.00262	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GNB3—hypertension	9.38e-05	0.00262	CbGpPWpGaD
Desonide—Headache—Doxazosin—hypertension	9.34e-05	0.000643	CcSEcCtD
Desonide—Pain—Losartan—hypertension	9.32e-05	0.000642	CcSEcCtD
Desonide—Rash—Fosinopril—hypertension	9.29e-05	0.000639	CcSEcCtD
Desonide—Dermatitis—Fosinopril—hypertension	9.28e-05	0.000639	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—AVP—hypertension	9.25e-05	0.00259	CbGpPWpGaD
Desonide—Rash—Eplerenone—hypertension	9.23e-05	0.000636	CcSEcCtD
Desonide—Headache—Fosinopril—hypertension	9.23e-05	0.000635	CcSEcCtD
Desonide—Dermatitis—Eplerenone—hypertension	9.23e-05	0.000635	CcSEcCtD
Desonide—Headache—Eplerenone—hypertension	9.17e-05	0.000632	CcSEcCtD
Desonide—Rash—Nifedipine—hypertension	9.17e-05	0.000631	CcSEcCtD
Desonide—Nervous system disorder—Ramipril—hypertension	9.16e-05	0.000631	CcSEcCtD
Desonide—Dermatitis—Nifedipine—hypertension	9.16e-05	0.00063	CcSEcCtD
Desonide—Rash—Verapamil—hypertension	9.13e-05	0.000628	CcSEcCtD
Desonide—Dermatitis—Verapamil—hypertension	9.12e-05	0.000628	CcSEcCtD
Desonide—Headache—Nifedipine—hypertension	9.11e-05	0.000627	CcSEcCtD
Desonide—Pruritus—Clonidine—hypertension	9.09e-05	0.000626	CcSEcCtD
Desonide—Skin disorder—Ramipril—hypertension	9.08e-05	0.000625	CcSEcCtD
Desonide—Infection—Timolol—hypertension	9.08e-05	0.000625	CcSEcCtD
Desonide—Headache—Verapamil—hypertension	9.07e-05	0.000624	CcSEcCtD
Desonide—Cough—Lisinopril—hypertension	9.06e-05	0.000624	CcSEcCtD
Desonide—Amcinonide—NR3C1—hypertension	9.04e-05	0.0165	CrCbGaD
Desonide—Budesonide—NR3C1—hypertension	9.04e-05	0.0165	CrCbGaD
Desonide—Hyperhidrosis—Ramipril—hypertension	9.03e-05	0.000622	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CXCL8—hypertension	9.03e-05	0.00253	CbGpPWpGaD
Desonide—Nervous system disorder—Timolol—hypertension	8.96e-05	0.000617	CcSEcCtD
Desonide—Skin disorder—Timolol—hypertension	8.87e-05	0.000611	CcSEcCtD
Desonide—Pruritus—Trandolapril—hypertension	8.86e-05	0.00061	CcSEcCtD
Desonide—Hyperhidrosis—Timolol—hypertension	8.83e-05	0.000608	CcSEcCtD
Desonide—Pruritus—Enalapril—hypertension	8.83e-05	0.000608	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	8.78e-05	0.000604	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—NEDD4L—hypertension	8.75e-05	0.00245	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PPARA—hypertension	8.73e-05	0.00244	CbGpPWpGaD
Desonide—Pruritus—Telmisartan—hypertension	8.71e-05	0.000599	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL10—hypertension	8.7e-05	0.00243	CbGpPWpGaD
Desonide—Mometasone—NR3C1—hypertension	8.6e-05	0.0157	CrCbGaD
Desonide—Rimexolone—NR3C1—hypertension	8.5e-05	0.0155	CrCbGaD
Desonide—Rash—Valsartan—hypertension	8.5e-05	0.000585	CcSEcCtD
Desonide—Dermatitis—Valsartan—hypertension	8.49e-05	0.000584	CcSEcCtD
Desonide—NR3C1—Adipogenesis—HIF1A—hypertension	8.48e-05	0.00237	CbGpPWpGaD
Desonide—Pruritus—Captopril—hypertension	8.47e-05	0.000583	CcSEcCtD
Desonide—Rash—Olmesartan—hypertension	8.46e-05	0.000582	CcSEcCtD
Desonide—NR3C1—Adipogenesis—AGT—hypertension	8.45e-05	0.00236	CbGpPWpGaD
Desonide—Dermatitis—Olmesartan—hypertension	8.45e-05	0.000582	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—hypertension	8.44e-05	0.00236	CbGpPWpGaD
Desonide—Headache—Valsartan—hypertension	8.44e-05	0.000581	CcSEcCtD
Desonide—Infection—Lisinopril—hypertension	8.42e-05	0.00058	CcSEcCtD
Desonide—Headache—Olmesartan—hypertension	8.4e-05	0.000578	CcSEcCtD
Desonide—NR3C1—Adipogenesis—LEP—hypertension	8.28e-05	0.00232	CbGpPWpGaD
Desonide—Skin disorder—Lisinopril—hypertension	8.23e-05	0.000567	CcSEcCtD
Desonide—Pruritus—Perindopril—hypertension	8.22e-05	0.000566	CcSEcCtD
Desonide—Pruritus—Irbesartan—hypertension	8.19e-05	0.000564	CcSEcCtD
Desonide—Hyperhidrosis—Lisinopril—hypertension	8.19e-05	0.000564	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—hypertension	8.18e-05	0.00229	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP9—hypertension	8.17e-05	0.00228	CbGpPWpGaD
Desonide—Pruritus—Hydrochlorothiazide—hypertension	8.13e-05	0.000559	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—PTEN—hypertension	8.12e-05	0.00227	CbGpPWpGaD
Desonide—Rash—Clonidine—hypertension	8.1e-05	0.000558	CcSEcCtD
Desonide—Dermatitis—Clonidine—hypertension	8.09e-05	0.000557	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—NGF—hypertension	8.09e-05	0.00226	CbGpPWpGaD
Desonide—Headache—Clonidine—hypertension	8.05e-05	0.000554	CcSEcCtD
Desonide—Fluocinonide—NR3C1—hypertension	8.02e-05	0.0146	CrCbGaD
Desonide—Beclomethasone—NR3C1—hypertension	8.02e-05	0.0146	CrCbGaD
Desonide—Pruritus—Furosemide—hypertension	7.99e-05	0.00055	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—hypertension	7.96e-05	0.00223	CbGpPWpGaD
Desonide—Pruritus—Betaxolol—hypertension	7.91e-05	0.000545	CcSEcCtD
Desonide—Rash—Trandolapril—hypertension	7.9e-05	0.000544	CcSEcCtD
Desonide—Dermatitis—Trandolapril—hypertension	7.89e-05	0.000543	CcSEcCtD
Desonide—Rash—Enalapril—hypertension	7.87e-05	0.000542	CcSEcCtD
Desonide—Dermatitis—Enalapril—hypertension	7.86e-05	0.000541	CcSEcCtD
Desonide—Headache—Trandolapril—hypertension	7.85e-05	0.00054	CcSEcCtD
Desonide—Headache—Enalapril—hypertension	7.82e-05	0.000538	CcSEcCtD
Desonide—Pain—Timolol—hypertension	7.81e-05	0.000538	CcSEcCtD
Desonide—Alclometasone—NR3C1—hypertension	7.79e-05	0.0142	CrCbGaD
Desonide—Fluocinolone Acetonide—NR3C1—hypertension	7.79e-05	0.0142	CrCbGaD
Desonide—Rash—Telmisartan—hypertension	7.76e-05	0.000534	CcSEcCtD
Desonide—Dermatitis—Telmisartan—hypertension	7.75e-05	0.000534	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—EP300—hypertension	7.74e-05	0.00217	CbGpPWpGaD
Desonide—Pruritus—Losartan—hypertension	7.71e-05	0.000531	CcSEcCtD
Desonide—Headache—Telmisartan—hypertension	7.71e-05	0.000531	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—hypertension	7.7e-05	0.00215	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—GATA4—hypertension	7.61e-05	0.00213	CbGpPWpGaD
Desonide—Fludrocortisone—NR3C1—hypertension	7.59e-05	0.0138	CrCbGaD
Desonide—Flunisolide—NR3C1—hypertension	7.59e-05	0.0138	CrCbGaD
Desonide—Clobetasol propionate—NR3C1—hypertension	7.59e-05	0.0138	CrCbGaD
Desonide—Rash—Captopril—hypertension	7.55e-05	0.000519	CcSEcCtD
Desonide—Dermatitis—Captopril—hypertension	7.54e-05	0.000519	CcSEcCtD
Desonide—Headache—Captopril—hypertension	7.5e-05	0.000516	CcSEcCtD
Desonide—Paramethasone—NR3C1—hypertension	7.49e-05	0.0137	CrCbGaD
Desonide—Ciclesonide—NR3C1—hypertension	7.37e-05	0.0134	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—hypertension	7.33e-05	0.00205	CbGpPWpGaD
Desonide—Rash—Perindopril—hypertension	7.33e-05	0.000504	CcSEcCtD
Desonide—Dermatitis—Perindopril—hypertension	7.32e-05	0.000504	CcSEcCtD
Desonide—Fluorometholone—NR3C1—hypertension	7.31e-05	0.0133	CrCbGaD
Desonide—Rash—Irbesartan—hypertension	7.3e-05	0.000503	CcSEcCtD
Desonide—Dermatitis—Irbesartan—hypertension	7.29e-05	0.000502	CcSEcCtD
Desonide—Headache—Perindopril—hypertension	7.28e-05	0.000501	CcSEcCtD
Desonide—Headache—Irbesartan—hypertension	7.25e-05	0.000499	CcSEcCtD
Desonide—Pain—Lisinopril—hypertension	7.25e-05	0.000499	CcSEcCtD
Desonide—Rash—Hydrochlorothiazide—hypertension	7.24e-05	0.000499	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hypertension	7.24e-05	0.00203	CbGpPWpGaD
Desonide—Dermatitis—Hydrochlorothiazide—hypertension	7.24e-05	0.000498	CcSEcCtD
Desonide—NR3C1—Adipogenesis—PPARG—hypertension	7.21e-05	0.00202	CbGpPWpGaD
Desonide—Headache—Hydrochlorothiazide—hypertension	7.2e-05	0.000495	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hypertension	7.17e-05	0.00201	CbGpPWpGaD
Desonide—Rash—Furosemide—hypertension	7.12e-05	0.00049	CcSEcCtD
Desonide—Dermatitis—Furosemide—hypertension	7.12e-05	0.00049	CcSEcCtD
Desonide—Headache—Furosemide—hypertension	7.08e-05	0.000487	CcSEcCtD
Desonide—NR3C1—Adipogenesis—INS—hypertension	7.07e-05	0.00198	CbGpPWpGaD
Desonide—Methylprednisolone—NR3C1—hypertension	7.07e-05	0.0129	CrCbGaD
Desonide—Rash—Betaxolol—hypertension	7.05e-05	0.000485	CcSEcCtD
Desonide—Dermatitis—Betaxolol—hypertension	7.04e-05	0.000485	CcSEcCtD
Desonide—Headache—Betaxolol—hypertension	7.01e-05	0.000482	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hypertension	7e-05	0.00196	CbGpPWpGaD
Desonide—Clobetasol propionate—CYP1A1—hypertension	6.89e-05	0.0126	CrCbGaD
Desonide—Dexamethasone—CYP17A1—hypertension	6.89e-05	0.0126	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hypertension	6.89e-05	0.00193	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—TGFB1—hypertension	6.89e-05	0.00193	CbGpPWpGaD
Desonide—Rash—Losartan—hypertension	6.87e-05	0.000473	CcSEcCtD
Desonide—Dermatitis—Losartan—hypertension	6.86e-05	0.000473	CcSEcCtD
Desonide—NR3C1—Adipogenesis—IGF1—hypertension	6.84e-05	0.00191	CbGpPWpGaD
Desonide—Headache—Losartan—hypertension	6.83e-05	0.00047	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—hypertension	6.82e-05	0.00191	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hypertension	6.78e-05	0.0019	CbGpPWpGaD
Desonide—Dexamethasone—CYP11A1—hypertension	6.78e-05	0.0124	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—MYC—hypertension	6.75e-05	0.00189	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TGFB1—hypertension	6.73e-05	0.00188	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NPPA—hypertension	6.63e-05	0.00186	CbGpPWpGaD
Desonide—Pruritus—Ramipril—hypertension	6.61e-05	0.000455	CcSEcCtD
Desonide—NR3C1—Adipogenesis—SERPINE1—hypertension	6.5e-05	0.00182	CbGpPWpGaD
Desonide—Pruritus—Timolol—hypertension	6.46e-05	0.000445	CcSEcCtD
Desonide—Betamethasone—CYP19A1—hypertension	6.03e-05	0.011	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hypertension	6e-05	0.00168	CbGpPWpGaD
Desonide—Pruritus—Lisinopril—hypertension	6e-05	0.000413	CcSEcCtD
Desonide—Triamcinolone—NR3C1—hypertension	5.96e-05	0.0109	CrCbGaD
Desonide—Rash—Ramipril—hypertension	5.89e-05	0.000406	CcSEcCtD
Desonide—Dermatitis—Ramipril—hypertension	5.89e-05	0.000405	CcSEcCtD
Desonide—Headache—Ramipril—hypertension	5.85e-05	0.000403	CcSEcCtD
Desonide—Rash—Timolol—hypertension	5.76e-05	0.000397	CcSEcCtD
Desonide—Dermatitis—Timolol—hypertension	5.75e-05	0.000396	CcSEcCtD
Desonide—Headache—Timolol—hypertension	5.72e-05	0.000394	CcSEcCtD
Desonide—Dexamethasone—NOS2—hypertension	5.62e-05	0.0102	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—TP53—hypertension	5.54e-05	0.00155	CbGpPWpGaD
Desonide—Prednisone—NR3C1—hypertension	5.41e-05	0.00986	CrCbGaD
Desonide—Rash—Lisinopril—hypertension	5.34e-05	0.000368	CcSEcCtD
Desonide—Dermatitis—Lisinopril—hypertension	5.34e-05	0.000367	CcSEcCtD
Desonide—Headache—Lisinopril—hypertension	5.31e-05	0.000365	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—CTGF—hypertension	5.2e-05	0.00146	CbGpPWpGaD
Desonide—Hydrocortisone—CYP3A5—hypertension	5.1e-05	0.00931	CrCbGaD
Desonide—NR3C1—Gene Expression—NR3C2—hypertension	5.08e-05	0.00142	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL6—hypertension	5.07e-05	0.00142	CbGpPWpGaD
Desonide—Prednisolone—NR3C1—hypertension	4.98e-05	0.00909	CrCbGaD
Desonide—NR3C1—Adipogenesis—CDKN1A—hypertension	4.96e-05	0.00139	CbGpPWpGaD
Desonide—Betamethasone—NR3C1—hypertension	4.88e-05	0.00891	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—hypertension	4.88e-05	0.00137	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—ESR2—hypertension	4.76e-05	0.00133	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—hypertension	4.76e-05	0.00133	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1B—hypertension	4.56e-05	0.00128	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH2—hypertension	4.51e-05	0.00126	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—hypertension	4.47e-05	0.00125	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—HDAC1—hypertension	4.32e-05	0.00121	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NEDD4L—hypertension	4.21e-05	0.00118	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—AR—hypertension	4.2e-05	0.00118	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hypertension	4.16e-05	0.00116	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hypertension	4.12e-05	0.00115	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TGFB1—hypertension	4.1e-05	0.00115	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—EP300—hypertension	4.08e-05	0.00114	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hypertension	3.86e-05	0.00108	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TNF—hypertension	3.83e-05	0.00107	CbGpPWpGaD
Desonide—Hydrocortisone—NR3C1—hypertension	3.81e-05	0.00695	CrCbGaD
Desonide—Dexamethasone—CYP3A5—hypertension	3.8e-05	0.00694	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—VDR—hypertension	3.78e-05	0.00106	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—GATA4—hypertension	3.66e-05	0.00103	CbGpPWpGaD
Desonide—Dexamethasone—CYP19A1—hypertension	3.51e-05	0.0064	CrCbGaD
Desonide—Triamcinolone—PTGS2—hypertension	3.38e-05	0.00617	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—hypertension	3.31e-05	0.000926	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NPPA—hypertension	3.19e-05	0.000893	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PPARA—hypertension	3.19e-05	0.000891	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6—hypertension	3.09e-05	0.000865	CbGpPWpGaD
Desonide—Dexamethasone—NR3C1—hypertension	2.84e-05	0.00518	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH1—hypertension	2.79e-05	0.000781	CbGpPWpGaD
Desonide—Betamethasone—PTGS2—hypertension	2.77e-05	0.00506	CrCbGaD
Desonide—Prednisone—ALB—hypertension	2.73e-05	0.00499	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—hypertension	2.67e-05	0.000747	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PPARG—hypertension	2.63e-05	0.000737	CbGpPWpGaD
Desonide—Dexamethasone—CYP1A1—hypertension	2.58e-05	0.00471	CrCbGaD
Desonide—NR3C1—Gene Expression—CTGF—hypertension	2.51e-05	0.000701	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—SERPINE1—hypertension	2.37e-05	0.000664	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR2—hypertension	2.29e-05	0.000641	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH2—hypertension	2.17e-05	0.000607	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HDAC1—hypertension	2.08e-05	0.000582	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AR—hypertension	2.02e-05	0.000566	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—VDR—hypertension	1.82e-05	0.000509	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—H2AFX—hypertension	1.72e-05	0.000482	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PRKCA—hypertension	1.68e-05	0.000469	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—YWHAZ—hypertension	1.66e-05	0.000465	CbGpPWpGaD
Desonide—Dexamethasone—PTGS2—hypertension	1.61e-05	0.00294	CrCbGaD
Desonide—NR3C1—Gene Expression—PRKCD—hypertension	1.6e-05	0.000448	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PPARA—hypertension	1.53e-05	0.000429	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MYC—hypertension	1.5e-05	0.00042	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH1—hypertension	1.34e-05	0.000376	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PPARG—hypertension	1.27e-05	0.000355	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SERPINE1—hypertension	1.14e-05	0.00032	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MYC—hypertension	7.23e-06	0.000202	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—hypertension	5.01e-06	0.00014	CbGpPWpGaD
